PlainRecalls
FDA Devices Moderate Class II Terminated

AMIA Automated Peritoneal Dialysis System Product Usage: It is intended for automatic control of dialysate solution exchanges in the treatment of adult renal failure patients undergoing Peritoneal dialysis.

Reported: February 27, 2019 Initiated: December 11, 2018 #Z-0849-2019

Product Description

AMIA Automated Peritoneal Dialysis System Product Usage: It is intended for automatic control of dialysate solution exchanges in the treatment of adult renal failure patients undergoing Peritoneal dialysis.

Reason for Recall

Potential for the software on Automated PD System cyclers which can cause shortened dwell times during a Cycle-Based therapy

Details

Units Affected
7,688 devices
Distribution
Worldwide Distribution - US Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY. Distributed internationally to Canada and Japan.
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
AMIA Automated Peritoneal Dialysis System Product Usage: It is intended for automatic control of dialysate solution exchanges in the treatment of adult renal failure patients undergoing Peritoneal dialysis.. Recalled by Baxter Healthcare Corporation. Units affected: 7,688 devices.
Why was this product recalled?
Potential for the software on Automated PD System cyclers which can cause shortened dwell times during a Cycle-Based therapy
Which agency issued this recall?
This recall was issued by the FDA Devices on February 27, 2019. Severity: Moderate. Recall number: Z-0849-2019.